ARCHIVES

Cephalon To Plead Guilty, Pay $425M For Off-Label Marketing.

This article is from The Cancer Letter archive.

Vol. 34 No. 36 | October 3, 2008

Download PDF Visit The Full Archive

Related Articles

DCPC Board Kills Cost Sharing for CIS, Rejects Primary Care Prevention Effort Evaluation Budget

May 13, 1988

NCI Disappointed Over Response To Survey Leads; CRAG Proposals Inadequate, More Will Be Sought

August 6, 1976

Phase II Study Meets Primary Endpoint, Demonstrating Overall Survival of 5.2 Months

September 27, 2013

EntreMed Issued U.S. Patent For Active Parts Of Endostatin.

March 2, 2001

NCI Human Tissue Network Resources Available For Research

January 24, 1997

Duke Scientists Develop 3D Mammography Using CT

February 24, 2006